Baird Downgrades Robbins & Myers (RBN) to Neutral

January 10, 2008 7:38 AM EST

Baird downgrades Robbins & Myers (NYSE: RBN) from Outperform to Neutral, but increased price target from $76 to $80.

Robbins & Myers Inc. is engaged in supplying of engineered equipment and systems for applications in global energy, industrial, chemical and pharmaceutical markets.


Related Categories

Downgrades

Stocks Mentioned

RBN 23.44

+0.32 +1.38%
Volume: 225,998
Track RBN


Add Your Comment